Key Market Insights

• Close to 60 players, worldwide, have taken initiatives to develop exosome therapeutics; the market is characterized by the presence of start-ups and small companies
• The current pipeline features more than 120 exosome therapeutics that are being evaluated across different phases of development; most of these are designed for intravenous administration
• 3,000+ patients have been recruited / enrolled in clinical trials evaluating exosome related therapies and biomarkers across different geographies
• More than 530 grants have been awarded for the ongoing RD efforts for exosome therapeutics; University of California has been awarded the maximum grant amount of USD 21 million
• A variety of investors, having realized the benefits and future opportunities in this field, have invested more than USD 570 million across more than 30 instances, since 2017
• The rising interest of stakeholders in exosome therapeutics is also reflected by the increasing number of partnerships established by various industry and non-industry players
• Stakeholders have participated in various global events to discuss the research outcomes, and affiliated challenges as well as opportunities existing in this domain
• At present, more than 30 start-ups are driving innovation in this domain; a variety of RD initiatives have been undertaken by these players over the last few years for the development of exosome therapeutics
• Lack of efficacy, COVID-19 pandemic, limited patient enrollment, and scarce funding are among the key reasons that have led to the discontinuation of studies sponsored by various industry and non-industry players
• With the rising demand for therapeutic advances in drug safety, the market of exosome therapeutics is expected to grow at an annualized rate of 41% between 2029-2040
• The projected market opportunity is likely to be well distributed across different routes of administration, types of formulations and key geographical regions

Table of Contents

1. PREFACE

1.1.      Scope of the Report

1.2.      Market Segmentation

1.3.      Research Methodology

1.4.      Key Questions Answered

1.5.      Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1.      Overview of Exosomes

3.2.      Exosome Biogenesis

3.3.      Applications of Exosomes

3.4.      Mechanism of Exosome Therapy

3.5.      Advantages of Exosome Therapies

3.6.      Risks and Future Perspectives Associated with Exosome Therapeutics

4. EXOSOME THERAPEUTICS: MARKET LANDSCAPE

4.1.      Analysis Methodology and Key Parameters

4.2.      Exosome Therapeutics Market Landscape

4.3.      Exosome Therapeutics Developers

5. EXOSOME THERAPEUTICS DEVELOPERS: COMPANY PROFILES

5.1.      Coya Therapeutics

5.2.      Codiak BioSciences

5.4.      Evox Therapeutics

5.5.      Curexsys

5.6.      EV Therapeutics

5.7.      SHIFTBIO

6. EXOSOME THERAPEUTICS: DRUG PROFILES

6.1.      AEGLE Therapeutics

6.2.      AVEM Healthcare

6.3.      Cellular Biomedicine Group

6.4.      OBCTCD24

6.5.      ReNeuron

6.6.      Stem Cell Medicine

7. CLINICAL TRIAL ANALYSIS

7.1.      Analysis Methodology and Key Parameters

7.2.      Exosome Therapeutics: List of Clinical Trials

8. ACADEMIC GRANT ANALYSIS

8.1.      Analysis Methodology and Key Parameters

8.2.      Exosome Therapeutics: List of Academic Grants

8.3.      Analysis by Year of Grants Awarded

8.4.      Analysis by Amount Awarded per Year

8.5.      Analysis by Type of Funding Institute Center

8.6.      Analysis by Support Period

8.7.      Analysis by Purpose of Grant

8.8.      Word Cloud Analysis: Emerging Focus Area

8.9.      Analysis by Grant Activity Code

8.10.    Analysis by Location of Recipient Organizations

8.11.    Popular Recipient Organizations: Analysis by Number of Grants

8.12.    Popular Recipient Organizations: Analysis by Amount Awarded

8.13.    Analysis by Type of Recipient Organization

8.14.    Analysis by Study Section

8.15.    Analysis by Type of Grant Application

8.16.    Analysis by Funding Institute Center and Support Year

9. GLOBAL EVENT ANALYSIS

9.1.      Chapter Overview

9.2.      Scope and Methodology

9.3.      List of Global Events Related to Exosomes

10. PARTNERSHIPS AND COLLABORATIONS

10.1.    Chapter Overview

10.2.    Partnership Models

10.3.    Exosome Therapeutics: List of Partnerships and Collaborations

11. FUNDING AND INVESTMENT ANALYSIS

11.1.    Analysis Methodology and Key Parameters

11.2.    Type of Funding

11.3.    Exosome Therapeutics: List of Funding Instances

11.4.    Analysis by Year of Funding

11.5.    Analysis by Amount Invested

11.6.    Analysis by Type of Funding

11.7.    Analysis by Type of Funding and Amount Invested

11.8.    Analysis by Purpose of Funding

11.9.    Analysis by Target Disease Indication(s)

11.10. Analysis by Therapeutic Area

11.11. Most Active Players: Analysis by Number of Funding Instances

11.12. Most Active Players: Analysis by Amount Raised

11.13. Active Investors: Analysis by Number of Funding Instances

11.14. Distribution by Geography

11.15. Summary of Funding Activity

12. START-UP HEALTH INDEXING

12.1.    Analysis Methodology and Key Parameters

12.2.    Analysis by Pipeline Strength

12.3.    Analysis by Pipeline Maturity

12.4.    Analysis by Indication Diversity

12.5.    Analysis by Number of Partnerships

12.6.    Analysis by Financial Support

12.7.    Start-up Health Indexing: Roots Analysis Perspective

12.8.    Most Active Start-ups

13. CASE STUDY: EXOSOME DEVELOPMENT AND MANUFACTURING SERVICE PROVIDERS

13.1.    Chapter Overview

13.2.    Exosome Development and Manufacturing Service Providers Landscape

14. DRUG FAILURE ANALYSIS

14.1.    Methodology and Key Parameters

14.2.    Exosome Therapeutics: List of Failed Drug Candidates

15. MARKET SIZING AND OPPORTUNITY ANALYSIS

15.1.    Forecast Methodology and Key Assumptions

15.2.    Global Exosome Therapeutics Market, 2029-2040

16. EXECUTIVE INSIGHTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html

Learn from experts:  do you know about these emerging industry trends?

Exploring AI-based Digital Pathology

Rare Kidney Disorders: Future Miracle Drugs

Learn from our recently published whitepaper:-
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com